Paul J Carter
10PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 24, 2026
Fab-Fc and Fab-Fab interactions of variable strength and valency contribute to the high concentration viscosity of IgG1 antibodies.Joel Heisler, Jennifer L Hofmann, Zhenyu Tan
|Dec 15, 2025
Publisher Correction: Fifty years of monoclonals: the past, present and future of antibody therapeutics.Andrew C Chan, Greg D Martyn, Paul J Carter
|Aug 07, 2025
Fifty years of monoclonals: the past, present and future of antibody therapeutics.Andrew C Chan, Greg D Martyn, Paul J Carter
|Oct 18, 2024
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics.Paul J Carter, Valerie Quarmby
|Jul 19, 2024
Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutations.Joel Heisler, Daniel Kovner, Saeed Izadi
|Jun 06, 2024
Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies.Wen-Ting K Tsai, Yinyin Li, Zhaojun Yin
Pageof 2
Frequent Collaborators
4 joint publications
Saeed Izadi
2 joint publications
Andrew C Chan
2 joint publications
Greg D Martyn
2 joint publications
Jochen Brumm
2 joint publications
Joel Heisler
2 joint publications
Christoph Spiess
2 joint publications
Patrick Wu
1 joint publications
Diego Ellerman
1 joint publications
Weiru Wang
1 joint publications
Guanghui Han
